NIMH research showcased at A...( nical practice. A symposium chai...)

A symposium chaired by Grayson Norquist, M.D., Chairman, Department of Psychiatry, University of Mississippi School of Medicine, will discuss findings emerging from clinical trials of treatments in "real world" settings for schizophrenia, Alzheimer's disease, bipolar disorder, childhood and adolescent depression, and depression resistant to standard interventions.

The vast range of patient populations and settings in which psychiatrists work is well-reflected in the research track. Symposia will present new findings on targeted, early interventions for treating autism, an update on pediatric bipolar disorder, both psychopharmacologic and psychosocial approaches to treatment of eating disorders, and a review of research advances in late-life disorders.

Among specific advances to be discussed:

• Brain imaging reveals how psychotherapy and antidepressants affect brain circuitry to lift depression.
• Studies in rats uncover a molecular mechanism by which nurture can modify nature
• A suspect gene variant that boosts risk for psychosis triggers a telltale pattern of brain activity.
• Certain subgroups of teens with depression may respond better than others to treatment.

"We view our research track at the APA meeting as an extraordinary opportunity to inform the psychiatric profession, and the larger mental health field, about NIMH's commitment to work toward a long-term goal of personalized care for every individual who lives with a mental disorder," added Insel.

'"/>

Contact: Jules Asher
NIMHpress@nih.gov
301-443-4536
NIH/National Institute of Mental Health
18-May-2005